Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H1, 2021

Published: January 2021

No. of Pages: 2066

Price:

Single User License: US $ 2500 US $ 1875
Corporate User License: US $ 7500 US $ 5625

Report Description
Table of Contents

Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H1, 2021

Summary

GlobalData's clinical trial report, Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H1, 2021" provides an overview of Coronavirus Disease 2019 (COVID-19) Clinical trials scenario. This report provides top line data relating to the clinical trials on Coronavirus Disease 2019 (COVID-19) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

List of Tables
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Region, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, North America, Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2021*
Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, G7 Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, E7 Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Trial Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, by End Point Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Coronavirus Disease 2019 (COVID-19) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Region (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2021*
Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, G7 Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, E7 Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Phase (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Trial Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, by End Point Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Coronavirus Disease 2019 (COVID-19) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
GlobalData Methodology

Write comment about above report:

Published By: GlobalData

Product Code: GlobalData53362

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Coronavirus Disease (COVID-19) : Epidemiology Analysis and Forecast - March 2020 Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast - March 2020 Summary The report covers current epidemiology situation, forecast, and analysis of COVID-19 in March 2020, including forecast for key markets.T...
Coronavirus Disease (COVID-19) : Epidemiology Analysis and Forecast - Apr 2020 Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast - Apr 2020 Summary First reported in Wuhan, China, in December 2019, now more than 846,200 confirmed cases of COVID-19 are spread across 187 countries worldw...
Epidemiology Analysis and Forecast: Coronavirus Disease (COVID-19) - May 2020 Epidemiology Analysis and Forecast: Coronavirus Disease (COVID-19) - May 2020 Summary The report provide forecast for peak-week and return-to-normal week that will help the reader plan in this uncertain time, and highlights ...
Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020 Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020 Summary The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence ...
Use of Telemedicine in the United States (US) during the COVID-19 Pandemic - Coronavirus Disease 2019 (COVID-19) Sector Impact Use of Telemedicine in the United States (US) during the COVID-19 Pandemic - Coronavirus Disease 2019 (COVID-19) Sector Impact Summary Prior to the COVID-19 pandemic, telemedicine had not reached its full potential in the US...
Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coronavirus Disease 2019 (COVID-19) Pipeline Review, H1 2020, provides an overview of the Coronavirus Disease 2019 (COVID-19) (Inf...
Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020 Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020" provides an overview of Co...
Coronavirus Disease 2019 (COVID-19) - Pipeline and Clinical Trial Analysis - April 2020 Coronavirus Disease 2019 (COVID-19) - Pipeline and Clinical Trial Analysis - April 2020 Summary The biopharmaceutical industry has risen to meet the challenge posed by this novel virus: hundreds of companies across the globe...
Pipeline and Clinical Trial Analysis - Coronavirus Disease 2019 (COVID-19) - May 2020 Pipeline and Clinical Trial Analysis - Coronavirus Disease 2019 (COVID-19) - May 2020 Summary The biopharmaceutical industry has risen to meet the challenge posed by this novel virus: hundreds of companies across the globe h...
Coronavirus Disease 2019 (COVID-19) - Pipeline and Clinical Trial Analysis - June 2020 Coronavirus Disease 2019 (COVID-19) - Pipeline and Clinical Trial Analysis - June 2020 Summary The biopharmaceutical industry has risen to meet the challenge posed by this novel virus: hundreds of companies across the globe ...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *